BC Cancer, Vancouver Center

Vancouver, British Columbia V5Z 4E6

0 studies enrolling now · 2 studies all time

What they study most

BRAF V600E-mutant Metastatic Colorectal Cancer, Cervical Cancer

Studies at this site

• Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed